Atrial fibrillation is a well-known risk factor for stroke that often remains undetected; yet, the benefit of screening of asymptomatic individuals remains unclear. A recent randomized trial ...

Please provide your email address to receive an email when new articles are posted on . The AMALFI trial evaluated a completely remote approach to atrial fibrillation screening. Remote screening with ...

Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA). AMALFI ...

- The watch will begin shipping in EU as a medical device for continuous measurement of heart rate and arrhythmias at ECG-level accuracy CAESAREA, Israel, Feb. 10, 2021 /PRNewswire/ -- CardiacSense - ...

That's a potential message from a randomized trial that tested an AF screening strategy relying on an implantable loop recorder (ILR) in older adults without AF but with other stroke risk factors who ...

This review article presents a three-part true-life clinical vignette that illustrates how digital health technology can aid providers caring for patients with cardiovascular disease. Specific ...

They say the surest path to a person’s heart is through their stomach, but according to MindMics, it might actually be through the ears. The Massachusetts-based startup’s technology uses in-ear ...

Continuous rhythm monitoring after cardiac surgery held clues to help identify people prone to late postoperative atrial fibrillation (POAF) and any associated adverse events. In the RACE V ...

Madrid, Spain – 29 August 2025: A mail-based atrial fibrillation (AF) screening programme with ECG-patch monitoring led to a modest long-term increase in AF diagnosis and anticoagulation exposure in ...